Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Select Medical Holdings's EBIT per Share for the
three
months ended in Mar. 2026 was €0.79.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was €2.67.
During the past 12 months, the average EBIT per Share Growth Rate of Select Medical Holdings was 26.60% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 33.10% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -12.10% per year.
During the past 10 years, the average EBIT per Share Growth Rate was -2.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Select Medical Holdings's EBIT per Share or its related term are showing as below:
FRA:S24'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -31.5 Med: 2.5 Max: 33.1
Current: 33.1
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Select Medical Holdings was 33.10% per year. The lowest was -31.50% per year. And the median was 2.50% per year.
FRA:S24's 3-Year EBIT Growth Rate is ranked better than 74.29% of 529
companies
in the Healthcare Providers & Services industry
Industry Median: 12.7
vs FRA:S24: 33.10
Select Medical Holdings (FRA:S24) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Select Medical Holdings EBIT per Share Related Terms
Select Medical Holdings EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.67
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Select Medical Holdings (FRA:S24) has a EBIT per Share of €2.67 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Select Medical Holdings and its competitors. According to the industry distribution chart, Select Medical Holdings ranks #136 out of 529 companies in the Healthcare Providers & Services industry, placing it in the top 25.7%.
Is Select Medical Holdings' EBIT per Share too high?
Select Medical Holdings' current EBIT per Share is €2.67. Based on the distribution chart, Select Medical Holdings ranks #136 out of 529 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Select Medical Holdings has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Select Medical Holdings' EBIT per Share compare to SGRY and MD?
According to the Healthcare Providers & Services industry distribution chart, Select Medical Holdings ranks #136 out of 529 companies for EBIT per Share. This puts Select Medical Holdings in the upper half of its industry. The industry median EBIT per Share is 12.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 12.70, based on 529 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Select Medical Holdings and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 12.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Select Medical Holdings's current EBIT per Share is €2.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Select Medical Holdings stock overvalued right now?
Select Medical Holdings (FRA:S24) has a current EBIT per Share of €2.67. The stock's GF Value™ is €15.02, compared to a current price of €14.40 — trading 4.1% below its estimated fair value. The current EBIT per Share is €2.67. Select Medical Holdings' overall GF Score™ is 77/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Select Medical Holdings (FRA:S24), the current EBIT per Share is €2.67 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Select Medical Holdings (FRA:S24) Overvalued in 2026?
Based on GuruFocus' analysis, Select Medical Holdings stock appears to be undervalued.
The current stock price of €14.40 is trading 4.1% below its estimated GF Value™ of €15.02.
Key valuation signals for FRA:S24:
EBIT per Share: €2.67
GF Value™: €15.02 vs. price of €14.40 (4.1% below fair value)
No single metric tells the full story. See the FRA:S24 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Select Medical Holdings Corp is a healthcare company that operates through three segments: critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics. Critical illness recovery hospitals which derives maximum revenue consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. The rehabilitation hospital segment consists of hospitals designed to serve patients that require intensive physical rehabilitation care. Patients are typically admitted to critical illness recovery hospitals and rehabilitation hospitals from general acute care hospitals. The outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services.
77GF Score
Get the complete analysis for FRA:S24
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:S24 has been successfully added to your 
